Japan, Feb. 18 -- GILEAD SCIENCES INC,NURIX THERAPEUTICS INC has got intellectual property rights for 'BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF.' Other related details are as follows:
Application Number: JP,2025-022773
Category (FI): A61K31/5386,A61K31/4545,A61P37/02,A61P29/02,C07D487/04,140,A61P3/00,A61P35/02,C07D487/04,C07D519/00,311,C07D519/00,301,A61K47/55,A61P35/00,A61K31/5025
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Feb. 14, 2025
Publication Date: April 24, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....